Cellares vs Spark Therapeutics
Cellares vs Spark Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellares is on 54/100 and Spark Therapeutics on 58/100.
Where each one leads
Cellares
- funding raised: $327M against $82.8M
Spark Therapeutics
- our overall score: 58/100 against 54/100
- domain rating: 80/100 against 43/100
At a glance
| Measure | Cellares | Spark Therapeutics |
|---|---|---|
| What it is | The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2019 | 2013 |
| Headquarters | South San Francisco, USA | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellares | Spark Therapeutics |
|---|---|---|
| Total funding | $327M | $82.8M |
| Latest round | Funding Round | Series B |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellares | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 58/100 |
| Traction | 40/100 | 40/100 |
| Team | Not published | 90/100 |
| Search visibility | 15/100 | 13/100 |
| Quality | 78/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 43/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellares | Spark Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Cellares | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 0 negative across 4 threads | 1 positive, 0 negative across 3 threads |
“Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel.”r/CABAinvest
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Cellares vs Spark Therapeutics: common questions
Which is better, Cellares or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Cellares and Spark Therapeutics compare on the numbers?
Cellares leads on funding raised ($327M against $82.8M). Spark Therapeutics leads on our overall score (58/100 against 54/100), domain rating (80/100 against 43/100).
What do real users say about Cellares and Spark Therapeutics?
Cellares: 2 positive and 0 negative mentions across 4 Reddit threads we track, mostly in r/CABAinvest. Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Cellares review and pricing or the Spark Therapeutics review and pricing. You can also browse other Cellares alternatives we track.